Pediatrix Medical Group (NYSE:MD) Stock Price Down 3.8% - What's Next?

Key Points

• Pediatrix Medical Group's stock price fell by 3.8%, trading at $16.93, with a significant decrease in trading volume of 75% from the average.
• Analysts have varying ratings on the stock, with Zacks Research upgrading it to a "strong-buy" and an average target price of $16.79 despite a recent 7.1% year-over-year decline in revenue.
• The company reported earnings of $0.53 per share, surpassing expectations, while 97.71% of the stock is owned by institutional investors.

Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report)'s stock price traded down 3.8% during mid-day trading on Wednesday . The stock traded as low as $16.98 and last traded at $16.93. 185,324 shares changed hands during mid-day trading, a decline of 75% from the average session volume of 753,791 shares. The stock had previously closed at $17.60.

Wall Street Analysts Forecast Growth

MD has been the subject of several recent analyst reports. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Pediatrix Medical Group in a report on Wednesday. Zacks Research raised shares of Pediatrix Medical Group to a "strong-buy" rating in a report on Monday, August 11th. Wall Street Zen raised shares of Pediatrix Medical Group from a "buy" rating to a "strong-buy" rating in a report on Saturday. Leerink Partners raised their price objective on shares of Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a "market perform" rating in a report on Friday, September 5th. Finally, UBS Group raised their price objective on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a "neutral" rating in a report on Thursday, August 14th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $16.79.

Pediatrix Medical Group Trading Down 3.3%

The stock has a market capitalization of $1.48 billion, a P/E ratio of 13.16 and a beta of 1.26. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.80 and a quick ratio of 1.80. The business's 50 day simple moving average is $16.02 and its 200-day simple moving average is $14.46.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.42 by $0.11. The firm had revenue of $468.84 million for the quarter, compared to analysts' expectations of $464.37 million. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The business's revenue for the quarter was down 7.1% on a year-over-year basis. During the same period last year, the firm earned $0.34 earnings per share. As a group, analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Institutional Investors Weigh In On Pediatrix Medical Group

Institutional investors have recently added to or reduced their stakes in the stock. GAMMA Investing LLC lifted its position in Pediatrix Medical Group by 219.5% in the 1st quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock valued at $37,000 after acquiring an additional 1,765 shares in the last quarter. Marshall & Sullivan Inc. WA bought a new stake in Pediatrix Medical Group during the 2nd quarter worth about $41,000. Canada Pension Plan Investment Board bought a new stake in shares of Pediatrix Medical Group in the 2nd quarter valued at about $83,000. AlphaQuest LLC raised its holdings in shares of Pediatrix Medical Group by 16.0% in the 1st quarter. AlphaQuest LLC now owns 5,877 shares of the company's stock valued at $85,000 after purchasing an additional 811 shares during the period. Finally, Quantbot Technologies LP bought a new stake in shares of Pediatrix Medical Group in the 2nd quarter valued at about $99,000. 97.71% of the stock is owned by institutional investors.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.